Insiders · IMUX

Daniel Vitt

CEO and Director at Immunic, Inc. (IMUX)

Daniel Vitt has filed 15 insider reports with the SEC since March 2021, as CEO and Director at Immunic, Inc. (IMUX). Daniel Vitt made no open-market purchases or sales in the last 12 months. The latest filing, on June 29, 2026, reports grant or award at Immunic, Inc. (IMUX).

Filings
15
Companies
1
Bought on market
$65.8K
Sold on market
None

Companies where Daniel Vitt is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Immunic, Inc. logo
IMUX
Immunic, Inc.
CEO and Director29,000$65.8K$1.53$7.39+383%Jun 29, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Daniel Vitt with

Other insiders at the same companies

Questions about Daniel Vitt

What is Daniel Vitt's role at Immunic, Inc.?
Daniel Vitt reports to the SEC as CEO and Director at Immunic, Inc. (IMUX), according to the latest filing on June 29, 2026.
How many shares does Daniel Vitt own?
After the latest filing that states it, Daniel Vitt directly owned 29,000 shares of Immunic, Inc. (IMUX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Daniel Vitt bought or sold stock recently?
The most recent open-market purchase was on June 5, 2025: bought 15,000 shares of Immunic, Inc. (IMUX) for $11.6K at an average of $0.77.
How do I get alerts when Daniel Vitt files?
Follow Daniel Vitt on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Daniel Vitt (SEC CIK 0001773673). Totals count each trade once, skipping amendments whose original is on file, from Mar 2, 2021 on. View on SEC EDGAR · Get this as JSON